Galentic Pharma India Pvt Ltd — Tetracycline Exporter Profile
Indian Pharmaceutical Exporter · #2 for Tetracycline · $2.3M export value · DGFT Verified
Galentic Pharma India Pvt Ltd is the #2 Indian exporter of Tetracycline with $2.3M in export value and 85 verified shipments. Galentic Pharma India Pvt Ltd holds a 13.6% market share in Tetracycline exports across 13 countries.
Galentic Pharma India Pvt Ltd — Tetracycline Export Profile: Buyers & Destinations
Where Does Galentic Pharma India Pvt Ltd Export Tetracycline?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ETHIOPIA | $673.0K | 39 | 34.8% |
| NETHERLANDS | $309.2K | 16 | 16.0% |
| MOZAMBIQUE | $183.3K | 7 | 9.5% |
| UNITED ARAB EMIRATES | $118.4K | 7 | 6.1% |
| DENMARK | $100.0K | 2 | 5.2% |
| TANZANIA | $95.2K | 3 | 4.9% |
| PERU | $71.0K | 2 | 3.7% |
| ZIMBABWE | $64.0K | 2 | 3.3% |
| SRI LANKA | $61.6K | 4 | 3.2% |
| NAMIBIA | $54.7K | 2 | 2.8% |
Galentic Pharma India Pvt Ltd exports Tetracycline to 18 countries. The largest destination is ETHIOPIA accounting for 34.8% of Galentic Pharma India Pvt Ltd's Tetracycline shipments, followed by NETHERLANDS (16.0%) and MOZAMBIQUE (9.5%). These destinations reflect Galentic Pharma India Pvt Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tetracycline from Galentic Pharma India Pvt Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| IMRES B.V. | NETHERLANDS | $219.6K | 12 |
| PHARMACEUTICAL AND CHEMICAL | MOZAMBIQUE | $124.6K | 3 |
| CAROGA PHARMA ETHIOPIA PLC | ETHIOPIA | $103.4K | 6 |
| UNICEF SUPPLY DIVISION | DENMARK | $100.0K | 2 |
| ETHIOPIAN PHARMACEUTICALS | ETHIOPIA | $100.0K | 2 |
| ETHIOPIAN PHARMACEUTICALS SUPPLY | ETHIOPIA | $100.0K | 2 |
| YUNABEK TRADING PLC | ETHIOPIA | $76.5K | 6 |
| PLANET PHARMACEUTICALS LIMITED | TANZANIA | $71.3K | 2 |
| LABORATORIOS LANSIER S.A.C | PERU | $71.0K | 2 |
| BOLE TRADING PLC | ETHIOPIA | $70.7K | 6 |
Galentic Pharma India Pvt Ltd supplies Tetracycline to 36 buyers globally. The largest buyer is IMRES B.V. (NETHERLANDS), followed by PHARMACEUTICAL AND CHEMICAL (MOZAMBIQUE) and CAROGA PHARMA ETHIOPIA PLC (ETHIOPIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tetracycline Export Value and How Much Does Galentic Pharma India Pvt Ltd Contribute?
India exported $9.7M worth of Tetracycline through 2,829 shipments from 263 suppliers to 128 countries, serving 660 buyers globally. Galentic Pharma India Pvt Ltd contributes $2.3M to this total, accounting for 13.6% of India's Tetracycline exports. Galentic Pharma India Pvt Ltd ships Tetracycline to 18 countries through 36 buyers.
What Is the Average Shipment Value for Galentic Pharma India Pvt Ltd's Tetracycline Exports?
Galentic Pharma India Pvt Ltd's average Tetracycline shipment value is $27.2K per consignment, based on 85 shipments totaling $2.3M. The largest destination is ETHIOPIA (34.8% of Galentic Pharma India Pvt Ltd's Tetracycline exports).
How Does Galentic Pharma India Pvt Ltd Compare to Other Indian Tetracycline Exporters?
Galentic Pharma India Pvt Ltd ranks #2 among 263 Indian Tetracycline exporters with a 13.6% market share. The top 3 exporters are GALENTIC PHARMA INDIA PVT LTD ($2.3M), PRASHI PHARMA PRIVATE LIMITED ($1.5M), COHANCE LIFESCIENCES LIMITED ($1.5M). Galentic Pharma India Pvt Ltd processed 85 shipments to 13 destination countries.
What Tetracycline Formulations Does Galentic Pharma India Pvt Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINES TETRACYCLINE HCL OPHT | $492.6K | 16 |
| HARMLESS MEDICINES TETRACYCLINE HYDROCHL | $252.6K | 13 |
| HARMLESS MEDICINES TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% ,4G (Tetracycline Hydrochloride Ophthalmic Oin | $100.0K | 2 |
| HARMLESS MEDICINES NETRACYCLINE EYE OINTMENT 5g Oxytetracycline Eye Ointment | $71.3K | 2 |
| HARMLESS MEDICINES, TETRALAN SP, 6G (TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1%) | $71.0K | 2 |
| HARMLESS MEDICINES TETRACYCLINE HYDROCHLORIDE OINTMENT 3% USP,15G (Tetracycline Hydrochloride Ointment USP 3%) | $66.8K | 6 |
| HARMLESS MEDICINES TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1 5g Tetracycline Hydrochloride Ophthalmic Oint | $61.9K | 3 |
| HARMLESS MEDICINES TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1%, 5g (Tetracycline Hydrochloride Ophthalmic Oint | $58.7K | 4 |
| HARMLESS MEDICINES TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% 5G Tetracycline Hydrochloride Ophthalmic O | $58.2K | 2 |
| HARMLESS MEDICINES TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% , 5G(TETRACYCLINE HYDROCHLORIDE OPHTHALMIC ONOS | $55.7K | 3 |
Galentic Pharma India Pvt Ltd exports 36 distinct Tetracycline formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINES TETRACYCLINE HCL OPHT with 16 shipments worth $492.6K.
How Does Galentic Pharma India Pvt Ltd Compare to Nearest Tetracycline Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | GALENTIC PHARMA INDIA PVT LTD ★ | $2.3M | 85 | 13 | $27.2K |
| 3 | PRASHI PHARMA PRIVATE LIMITED | $1.5M | 63 | 4 | $23.4K |
| 4 | COHANCE LIFESCIENCES LIMITED | $1.5M | 36 | 1 | $40.5K |
Galentic Pharma India Pvt Ltd ranks #2 among 263 Indian Tetracycline exporters. Average shipment value of $27.2K compared to the market average of $36.8K. The closest competitors by value are PRASHI PHARMA PRIVATE LIMITED and COHANCE LIFESCIENCES LIMITED.
Which Indian Ports Ship Tetracycline Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 438 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 393 | 13.9% |
| SAHAR AIR | 355 | 12.5% |
| DELHI AIR | 253 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 224 | 7.9% |
| JNPT | 130 | 4.6% |
| Bombay Air | 121 | 4.3% |
| JNPT/ NHAVA SHEVA SEA | 114 | 4.0% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tetracycline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tetracycline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Galentic Pharma India Pvt Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 99 individual customs records matching Galentic Pharma India Pvt Ltd exporting Tetracycline, covering 36 formulations to 18 countries via 36 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 128+ countries, 660+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tetracycline Export Data from Galentic Pharma India Pvt Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Galentic Pharma India Pvt Ltd's Tetracycline exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Galentic Pharma India Pvt Ltd
Company Profile
0 products · $0 total trade · 0 categories
Tetracycline Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Galentic Pharma India Pvt Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tetracycline. For current shipment-level data, contact TransData Nexus.